What is 100Plus?
100Plus operates a sophisticated remote care platform, offering comprehensive remote patient monitoring (RPM) and chronic care management (CCM) solutions. The platform is engineered to elevate patient engagement and drive improved health outcomes. It is specifically designed for healthcare providers aiming to streamline their operational workflows, alleviate administrative burdens, and sustain continuous patient connectivity between in-person appointments. The integration of artificial intelligence within the 100Plus system facilitates enhanced patient education and adherence to treatment plans. Furthermore, it provides robust reporting capabilities and seamless Electronic Health Record (EHR) integration, positioning 100Plus as a key enabler for healthcare practices focused on optimizing chronic disease management and boosting overall operational efficiency.
How much funding has 100Plus raised?
100Plus has raised a total of $25M across 1 funding round:
Angel/Seed
$25M
Angel/Seed (2021): $25M with participation from George Roberts and Henry Kravis
Key Investors in 100Plus
George Roberts
George Roberts, associated with www.scaffoldingsales.co.uk, participated in this funding round. The domain suggests a potential interest in industrial or infrastructure-related investments, though their specific focus within the healthcare technology sector remains to be detailed.
Henry Kravis
Henry Kravis, an investor in this round, has a background that often involves significant private equity and corporate finance activities. Their involvement may indicate a strategic interest in the long-term growth and market potential of 100Plus.
What's next for 100Plus?
The recent major strategic investment signals a pivotal growth phase for 100Plus, likely enabling the company to scale its operations, expand its market reach, and further develop its AI-driven remote care technologies. This enterprise-level backing suggests a strategic focus on solidifying its position in the competitive health-tech landscape, potentially through enhanced product development, strategic partnerships, or broader market penetration. The company is poised to leverage this capital to deepen its impact on chronic disease management and remote patient care.
See full 100Plus company page
